Glycopyrrolate for Injection 0.2 mg per 1 mL Single-Dose Vial 1 mL is a prescription medicine used in adults and children aged 3 months and older to treat reversible bronchospasm associated with chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. It is also used to prevent and control excessive secretions from the mouth and airways during surgical procedures and to treat severe drooling in patients with certain neurological conditions. Glycopyrrolate is a type of medication called an antimuscarinic or anticholinergic, which works by blocking the action of a chemical in the body called acetylcholine, and helps with muscle relaxation and reduces the amount of secretions made in the airways. It is given as an injection into a vein or muscle by a healthcare provider and is available in single-dose vials containing 1 mL of solution. The dose and frequency of administration will be determined by a doctor based on the individual's condition and response to treatment.

Glycopyrrolate injection is a medication used to reduce saliva and secretions before surgery. It belongs to a class of drugs known as anticholinergics.

Anticholinergics work by blocking the effects of a neurotransmitter called acetylcholine in the body. Acetylcholine is involved in various body functions, including the production of saliva and secretions. By blocking its effects, glycopyrrolate reduces the production of saliva and secretions, making breathing easier for patients during surgery.

The medication is injected intravenously (into a vein) before surgery and takes effect quickly, with peak effects occurring within 30 minutes. It may also be used in the management of excessive salivation associated with certain medical conditions such as Parkinson's disease and cystic fibrosis.

Overall, Glycopyrrolate for Injection helps to maintain dryness of the mouth and respiratory passages, enhancing the safety and comfort of patients during surgical procedures.